Karen Carver-Moore
- Molecular Biology top 2%
- Immunology top 1%
- Oncology top 1%
- Hematology top 0.5%
- Cancer Research top 1%
- Co-authors
- Mark W. MooreMary DowdKenneth J. HillanK. Sue O’SheaLyn Powell-BraxtonHelen ChenKathleen C. F. SheehanRobert D. Schreiber
- Topics
- Platelet Disorders and Treatments (7 papers)Blood groups and transfusion (4 papers)Cell Adhesion Molecules Research (3 papers)
- Cited by
- HematologyImmunologyCancer Research
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Karen Carver-Moore
16 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Biology 3.9k
- Immunology 1.9k
- Oncology 1.7k
- Hematology 1.6k
- Cancer Research 1.2k
Countries citing papers authored by Karen Carver-Moore
This map shows the geographic impact of Karen Carver-Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Carver-Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Carver-Moore more than expected).
Fields of papers citing papers by Karen Carver-Moore
This network shows the impact of papers produced by Karen Carver-Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Carver-Moore. The network helps show where Karen Carver-Moore may publish in the future.
Co-authorship network of co-authors of Karen Carver-Moore
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Carver-Moore. A scholar is included among the top collaborators of Karen Carver-Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Carver-Moore. Karen Carver-Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 92 | |
| 2 | 152 | |
| 3 | 131 | |
| 4 | 106 | |
| 5 | Renal and neuronal abnormalities in mice lacking GDNFbreakdown → | 1035 |
| 6 | 355 | |
| 7 | Heterozygous embryonic lethality induced by targeted inactivation of the VEGF genebreakdown → | 2849 |
| 8 | Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathwaybreakdown → | 1415 |
| 9 | 287 | |
| 10 | 229 | |
| 11 | 174 | |
| 12 | 14 | |
| 13 | Thrombocytopenia in c-mpl-deficient micebreakdown → | 529 |
| 14 | Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient micebreakdown → | 519 |
| 15 | 19 | |
| 16 | 12 |
About Karen Carver-Moore
Karen Carver-Moore is a scholar working on Hematology, Immunology and Allergy and Genetics, having authored 16 papers that have together received 7.9k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (7 papers), Blood groups and transfusion (4 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Hematology (1.6k citations), Immunology (1.9k citations) and Cancer Research (1.2k citations). Karen Carver-Moore has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Mark W. Moore, Mary Dowd, Kenneth J. Hillan, K. Sue O’Shea, Lyn Powell-Braxton, Helen Chen, Kathleen C. F. Sheehan, Robert D. Schreiber, Austin Gurney and Frédéric J. de Sauvage. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.